The effects of ultrafiltration on e-aminocaproic acid: an in vitro analysis.

Blood conservation strategies have become a standard of practice in cardiac surgery, with the use of antifibrinolytic agents and ultrafiltration two popular techniques. The purpose of this study was to evaluate the effects of continuous ultrafiltration on e-aminocaproic acid (EACA) utilizing functional coagulation analysis. A fibrinolytic assay was developed to detect EACA using the thromboelastograph (TEG) and urokinase (0.138 units 0.360 mL(-1)). Fresh bovine blood (23 +/- 1% hematocrit) was pumped (100 mL min(-1)) through an ultrafiltrator (HPH 400) at 37 degrees C with a transmembrane pressure of 280 mmHg. EACA (0.065 mg mL(-1)) was circulated for 10 minutes before initiating ultrafiltration. Samples (pre- and postultrafiltrator) were obtained at baseline, 5, and 10 min of ultrafiltration and analyzed via the fibrinolytic assay for EACA determination. TEG profiles significantly decreased from concentrations of 0.065 mg to 0.0325 mg of EACA mL(-1) blood (maximum amplitude MA, 75.4 +/- 4.0 versus 63.3 +/- 2.9, p < .05, TEG index 5.4 +/- 0.7 versus 4.0 +/- 0.3, p < .05). Fibrinolysis at 30 min increased as EACA concentrations declined (0.065 mg, 0% versus 0.032 mg, 16.4 +/- 2.8%, p < .05). During ultrafiltration the MA increased significantly from baseline to 10 min postultrafiltrator (68.2 +/- 3.0 versus 75.8 +/- 10.0, p < .05) and from 5 min pre- to 10 min postultrafiltrator (69.7 +/- 4.2 versus 75.8 +/- 10.0, p < .05). The TEG index showed no significant change, and no fibrinolysis was detected at 30 min from any datapoint during ultrafiltration. In conclusion, this study demonstrates that the antifibrinolytic properties of EACA are maintained during ultrafiltration with a 25% reduction in total circulating volume.

[1]  A. Stammers,et al.  Effects of ultrafiltration on enoxaparin: an in vitro analysis. , 2001, The journal of extra-corporeal technology.

[2]  A. Stammers,et al.  A retrospective study on perfusion incidents and safety devices , 2000, Perfusion.

[3]  I. Stefanidis,et al.  Hirudin elimination by hemofiltration: a comparative in vitro study of different membranes. , 1999, Kidney international. Supplement.

[4]  M. Csete,et al.  Fatal pulmonary embolism during liver transplantation. , 1997, Anesthesiology.

[5]  Beverly D Seymour,et al.  Rhabdomyolysis Induced by Epsilon-Aminocaproic Acid , 1997, The Annals of pharmacotherapy.

[6]  P. Kuo,et al.  Intracardiac thrombus formation during orthotopic liver transplantation: a new entity or an old enemy? , 1996, Transplantation.

[7]  A. Stammers,et al.  Evaluation of the Thrombelastograph Targeted Coagulation Assessment , 1996, The Journal of ExtraCorporeal Technology.

[8]  K. Saving,et al.  Fatal aortic thrombosis in a neonate during infusion of epsilon-aminocaproic acid. , 1995, Journal of pediatric surgery.

[9]  D. Larson,et al.  Hemofiltration: determinants of drug loss and concentration. , 1995, The journal of extra-corporeal technology.

[10]  S. Winter,et al.  ϵ‐Aminocaproic Acid‐Associated Myopathy in a Child , 1995 .

[11]  J. Mark,et al.  Early thrombus formation on heparin-bonded pulmonary artery catheters in patients receiving epsilon aminocaproic acid. , 1995, Anesthesiology.

[12]  J. Newberry,et al.  Coagulation monitoring during extracorporeal membrane oxygenation: the role of thrombelastography. , 1995, The journal of extra-corporeal technology.

[13]  R. Radovancevic,et al.  The hematologic effects of cardiopulmonary bypass and the use of hemotherapy in coronary artery bypass grafting. , 1994, Archives of pathology & laboratory medicine.

[14]  R. Emery,et al.  Decreased postoperative drainage with addition of epsilon-aminocaproic acid before cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.

[15]  S. Miyakawa,et al.  Contact dermatitis from epsilon‐aminocaproic acid , 1993, Contact dermatitis.

[16]  G. Lemole,et al.  Prophylactic treatment of postperfusion bleeding using EACA. , 1989, Chest.

[17]  W. Bennett,et al.  Drug Removal by Continuous Arteriovenous Haemofiltration , 1988, Medical toxicology and adverse drug experience.

[18]  A. Greenberg,et al.  Acute Renal Failure Due to High-Grade Obstruction Following Therapy With ϵ-Aminocaproic Acid , 1986 .

[19]  A. Greenberg,et al.  Acute renal failure due to high-grade obstruction following therapy with epsilon-aminocaproic acid. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  A. Atkinson,et al.  Kinetics of epsilon‐aminocaproic acid distribution, elimination, and antifibrinolytic effects in normal subjects , 1984, Clinical pharmacology and therapeutics.

[21]  R. Glick,et al.  High does epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage. , 1981, Neurosurgery.

[22]  S. Fish,et al.  Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis. , 1981, Journal of neurosurgery.

[23]  E. K. Christensen.  [epsilon-aminocaproic acid]. , 1962, Pharmaceutisch weekblad.